Watchlist Price Alert

Mersana Therapeutics Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

0.36

0.04 (12.89%)

At close: May 12, 2025, 3:59 PM

0.36

0.76%

After-hours: May 12, 2025, 07:47 PM EDT

Mersana Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	40.5M	36.85M	26.58M	43K	828K	42.12M	10.59M	17.55M	25.17M
Cost of Revenue	1.63M	148.27M	927K	132.01M	67.04M	55.04M	59.91M	928K	32.01M
Gross Profit	38.87M	-111.41M	25.65M	-131.97M	-66.21M	-12.92M	-49.32M	16.62M	-6.84M
Operating Income	-73.34M	-170.96M	-204.69M	-169.71M	-87.69M	-29.22M	-65.66M	-39.62M	-13.82M
Interest Income	8.44M	12.07M	2.88M	65K	424K	2.23M	1.4M	910K	121K
Pretax Income	-68.77M	-171.67M	-204.21M	-170.06M	-88.05M	-28.21M	-64.26M	-38.71M	-13.7M
Net Income	-69.19M	-171.67M	-207.54M	-169.21M	-88.4M	-27.2M	-64.26M	-38.71M	-13.7M
Selling & General & Admin	40.81M	59.54M	56.96M	36.89M	21.9M	17.28M	16.33M	10.46M	6.98M
Research & Development	73.02M	148.27M	173.38M	132.01M	67.04M	55.04M	59.91M	46.7M	32.01M
Other Expenses	n/a	n/a	-445K	-1.2M	n/a	n/a	1.4M	n/a	n/a
Operating Expenses	113.83M	36.85M	230.35M	168.9M	88.94M	72.32M	76.25M	57.16M	38.99M
Interest Expense	3.87M	4.07M	3.33M	1.27M	359K	234K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	113.83M	207.81M	230.35M	168.9M	88.94M	72.32M	76.25M	57.16M	38.99M
Income Tax Expense	418K	n/a	3.33M	-855K	359K	-1.01M	1.4M	n/a	n/a
Shares Outstanding (Basic)	122.54M	116.11M	93.65M	70.58M	61.49M	43.4M	23.03M	12.02M	17.49M
Shares Outstanding (Diluted)	122.54M	116.11M	93.65M	70.58M	61.49M	43.49M	23.03M	12.02M	17.49M
EPS (Basic)	-0.56	-1.48	-2.22	-2.4	-1.44	-0.63	-2.79	-3.22	-0.78
EPS (Diluted)	-0.56	-1.48	-2.22	-2.4	-1.44	-0.63	-2.79	-3.22	-0.78
EBITDA	-63.27M	-166.08M	-199.96M	-167.94M	-86.68M	-26.73M	-63M	-37.78M	-13.17M
EBIT	-64.9M	-167.6M	-200.88M	-168.79M	-87.69M	-27.97M	-64.26M	-38.71M	-13.82M
Depreciation & Amortization	1.63M	1.52M	927K	855K	1.01M	1.25M	1.26M	928K	655K